Stay updated on Nab-Sirolimus+Pazopanib in Nonadipocytic Soft Tissue Sarcomas Clinical Trial

Sign up to get notified when there's something new on the Nab-Sirolimus+Pazopanib in Nonadipocytic Soft Tissue Sarcomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nab-Sirolimus+Pazopanib in Nonadipocytic Soft Tissue Sarcomas Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The record describes a University of Washington phase 1/2 study of nab-sirolimus with pazopanib for advanced nonadipocytic soft-tissue sarcoma. It also provides study eligibility and outcome details, posted results and documents, and notes that the trial was terminated after phase 1 dose escalation due to loss of financial support.
    Difference
    55%
    Check dated 2026-11-07T13:10:00.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-10-31T13:57:31.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    A sitewide notice announces the NIH transition from “Artificial Intelligence” to “Super Intelligence” terminology and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-24T16:14:20.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The site footer revision label changes from v3.7.1 to v3.7.2, while the study page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-17T16:06:43.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The footer revision number changes from v3.7.0 to v3.7.1; the study record remains inaccessible behind a 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-10T16:07:33.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Difference
    20%
    Check dated 2026-09-19T20:39:08.000Z thumbnail image

Stay in the know with updates to Nab-Sirolimus+Pazopanib in Nonadipocytic Soft Tissue Sarcomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nab-Sirolimus+Pazopanib in Nonadipocytic Soft Tissue Sarcomas Clinical Trial page.